Related Experiment Videos
Somatostatin: widespread abnormality in tissues of spontaneously diabetic mice
Abstract:
Diabetic mice of the C57BL/6J obob and C57BL/Ks dbdb strains show a reduction in pancreatic somatostatin concentration accompanied in the obob strain by a striking decrease in the number of somatostatin-containing cells in the islets. Somatostatin concentration is also decreased in the stomach but increased in the hypothalamus. These findings suggest different control mechanisms for somatostatin in the hypothalamus compared to the gut and pancreas and exclude a primary genetic abnormality of somatostatin cells in the mutants.
Insights
Diabetic mice exhibit altered somatostatin levels, with decreased pancreatic and stomach concentrations but increased hypothalamic levels. This suggests distinct regulatory mechanisms for somatostatin in different organs.
Area of Science:
- Endocrinology
- Neuroscience
- Metabolic Research
Background:
- Diabetes mellitus is a complex metabolic disorder.
- Somatostatin plays a crucial role in regulating various physiological processes, including hormone secretion and gastrointestinal function.
- Previous research indicates potential alterations in somatostatin in diabetic states.
Purpose of the Study:
- To investigate the impact of genetic diabetes on somatostatin levels in pancreatic islets, stomach, and hypothalamus.
- To explore potential differences in somatostatin regulation between the central nervous system and peripheral organs in diabetic models.
Main Methods:
- Utilized two established mouse models of genetic diabetes: C57BL/6J obob and C57BL/Ks dbdb.
- Measured somatostatin concentration in pancreatic tissue, stomach, and hypothalamus.
- Quantified the number of somatostatin-containing cells in pancreatic islets of the obob strain.
Main Results:
- Diabetic mice showed reduced pancreatic somatostatin concentration.
- The C57BL/6J obob strain exhibited a significant decrease in somatostatin-containing cells within pancreatic islets.
- Somatostatin levels were decreased in the stomach but increased in the hypothalamus of diabetic mice.
Conclusions:
- The study suggests distinct regulatory mechanisms for somatostatin in the hypothalamus compared to the gut and pancreas.
- Findings exclude a primary genetic abnormality of somatostatin cells as the cause of observed changes in these diabetic mutants.
- Altered somatostatin distribution in diabetes highlights complex neuroendocrine dysregulation.